What's New
Withdrawal of dosulepin (dothiepin) and doxepin from New ZealandJuly 18, 2019
Two tricyclic antidepressants (TCAs), dosulepin (dothiepin) and doxepin will no longer be available in New Zealand. When transitioning patients to alternatives, consider: Is a TCA still appropriate? TCAs are associated with a higher risk of adverse outcomes in people with cardiovascular disease and older adults. Individual psychiatric history. Switching therapy increases the risk of relapse […]
MMR vaccination and immunosuppressantsMarch 12, 2019
The Immunisation Advisory Centre have provided an information sheet about diseases and medications when live attenuated vaccines (e.g. MMR) may be contraindicated – See www.immune.org.nz or the PDFÂ below. Health professionals are welcome to contact our service if unsure about any medicines. AdministrationImmunecompLiveVac20180507V02Final